Apollo Hospitals has launched what it calls India’s first dedicated Centre for Venous Disorders at its Chennai facility, consolidating diagnosis, intervention, and rehabilitation for chronic venous disease (CVD) under one roof. A full rollout across the group’s 70-plus hospital network is planned within the 2026 calendar year.
What the centre offers
The programme brings together vascular surgeons, interventional radiologists, and dermatologists trained in phlebology. Treatment options include endovenous laser ablation (EVLA), radiofrequency ablation (RFA), ultrasound-guided foam sclerotherapy, and venoplasty for post-thrombotic syndrome.
Apollo has attached a dedicated deep vein thrombosis (DVT) prevention clinic to the programme, targeting high-risk surgical and oncology patients across its network — a cohort vascular specialists consider the most acutely underserved segment in Indian hospitals.
Why this matters now
CVD — encompassing varicose veins, DVT, and chronic venous insufficiency — affects roughly 30% of Indian adults but remains underdiagnosed in Tier 2 and Tier 3 cities where specialist access is thin. India’s National Programme for Non-Communicable Diseases (NP-NCD), administered by the Union Ministry of Health and Family Welfare, tracks cardiovascular and metabolic conditions but carries no separate venous disease category, leaving policymakers without granular burden data.
The cost gap for late presenters is stark. Varicose veins account for roughly 1 in 5 outpatient vascular referrals at tertiary hospitals in Maharashtra and Tamil Nadu, yet most patients arrive after skin ulceration has set in. Late-stage cases cost 3 to 4 times more to treat than early-intervention cases and require longer inpatient stays.
ℹ️ What is chronic venous disease?
- CVD occurs when leg veins fail to return blood efficiently to the heart, causing pressure build-up.
- Common presentations: varicose veins, leg swelling, skin discolouration, and venous ulcers.
- Risk factors include prolonged sitting or standing, obesity, pregnancy, and family history.
- DVT is the most dangerous form — clots can migrate to the lungs, causing pulmonary embolism.
Apollo’s broader vascular push
The venous centre is part of Apollo’s 2025-26 specialty expansion roadmap. Since April 2025 the group has added 3 cardiac catheterisation labs and 2 robotic surgery suites. Apollo reported consolidated revenue of ₹6,477 crore for Q3 FY26, with its hospitals segment contributing ₹3,183 crore — the margin that finances capital-intensive specialty builds of this kind.
FAQ
Which Apollo hospital has the venous disorders centre?
Are varicose vein treatments covered under health insurance in India?
What is the difference between varicose veins and DVT?
Apollo has indicated the centre will publish outcome data — including procedural success rates and 12-month recurrence figures — by March 2027. If delivered, that dataset would give Indian vascular medicine its first large-scale, multi-centre registry for venous interventions.
